Clinical Trials Browser

Phase 1/2 × Terminated × Daunorubicin × Clear all

NCT03724084 2025-06-18

Pinometostat With Standard Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and MLL Gene Rearrangement

Phase 1/2 Terminated

6 enrolled 13 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00219765 2005-11-28

Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients

Phase 1/2 Terminated

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive